End of this page section.

Begin of page section: Contents:

Network Pharmacology (Stelzl)

From molecular interaction networks to personalized drug treatment
 

Stelzl, Ulrich, Univ.-Prof. Dipl.-Ing. Dr.rer.nat.   

Fasching, Sandra, BSc MSc.

Jany-Luig, Evelyne, M.Sc.

Kohlmayr, Johanna; Mag.pharm.

Kunowska, Natalia, Dr.rer.nat.

Mößlacher, Christina Stefanie

Smolnig, Martin, BSc MSc.
 

News

Open position:
Tenure-track professorship Computational Pharmacology

We are part of MOBILES

News on uni.on (german only)

Announcements of the Institute of Pharmaceutical Sciences

 

Research summary

The group is focusing on the analysis of molecular interaction networks with the aim to understand the dynamics of molecular networks underlying cellular processes related to human disease. Experimental functional genomics techniques, e.g. HTP Y2H screening, are utilized in combination with biochemical, cell biological and computational methods.

Current DNA sequencing approaches and mass spectrometry based proteomics technologies allow the simultaneous measurements of gene/protein variants for series of cell types, conditions or disease states. In particular the discovery of new somatic mutations in health and disease has vastly outpaced our ability to assess their functional roles. As most of the variation alone is not causal with respect to the observed phenotype, the question arises how to systematically analyze the large number of molecular variation and how to assess the importance of combined changes for cellular function, disease development and drug action? In our work we focus on the systematic analyses of the functional impact of genetic variation and post-translational protein modification on protein-protein interaction, which as universal protein function underlies cellular phenotypes. Using deep scanning mutagenesis approaches we bridge the knowledge gap between nucleotide resolution genomics and protein resolution proteomics.

Network biology offers a more comprehensive understanding of biological processes. Advances in systems biology indicate that complex diseases may not be treated effectively by interventions at single drug targets and with single drugs. Network biology will advance our understanding of drug action and will be an important piece in developing individualized medicine.
 

Recommended reading on interaction networks / network biology / network pharmacology:

Systematic interaction studies in human disease research, a technology feature free at Nature magazine: Protein maps chart the causes of disease by Marissa Fessenden (Bozeman|Montana)

A new discipline: network science !? An insight commentary at Nature Physics suggests ...  The network takeover by Albert-László Barabási (Boston|Massachusetts)

 

Publications

Updated research records can be found at
pubmed, PMC Europe, google scholar, scopus or researcherID.  
 

Recent selected publications

Woodsmith J, Casado-Medrano V, Benlasfer N, Eccles RL, Hutten S, Heine CL, Thormann V, Abou-Ajram C, Rocks O, Dormann D, Stelzl U (2018)
Interaction modulation through arrays of clustered methyl-arginine protein modifications.
Life Sci Alliance 1: e201800178.
OA article link at EMBO press

Woodsmith J, Apelt L, Casado-Medrano V, Özkan Z, Timmermann B, Stelzl U (2017)
Protein interaction perturbation profiling at amino-acid resolution.
Nat Methods 14: 1548-7091.
PMID: 29039417
article link at nature methods

Corwin T, Woodsmith J, Apelt F, Fontaine JF, Meierhofer D, Helmuth J, Grossmann A, Andrade-Navarro MA, Ballif BA, Stelzl U (2017)
Defining Human Tyrosine Kinase Phosphorylation Networks Using Yeast as an In Vivo Model Substrate.
Cell Syst. 5:128-139.
PMID: 28837810
article link free at cell press

To top

Contact

Institute of Pharmaceutical Sciences
Universitätsplatz 1/I A-8010 Graz
Pharmaceutical Chemistry Phone:+43 (0)316 380 - 5365
Fax:+43 (0)316 380 - 9846

End of this page section.

Begin of page section: Additional information:


End of this page section.